OTC · Software - Application

Rayont Inc. (RAYT) Stock

$0.03 +0.00% OTC: RAYT Technology

Rayont Inc., primarily operating through its subsidiary THF Holdings Pty Ltd., specializes in the development of medical devices and cancer treatments. Established in 2011, the company maintains its headquarters in Southport, Australia, and was formerly recognized as Velt International Group Inc.

Valuation

MetricValue
Price$0.03
Market Cap$1.46M
P/E Ratio2.91
P/B Ratio0.27
P/S Ratio0.51
EPS (TTM)$0.01
52-Week High$0.10
52-Week Low$0.03
Dividend Yield—

Financials & Margins

MetricValue
ROE8.14%
ROA1.73%
ROCE8.57%
Gross Margin48.69%
Operating Margin31.15%
Net Margin8.62%
Debt/Equity1.54
Current Ratio0.98

Annual Financials (USD)

Metric20172018201920202022
Revenue$1.0M$0$0$0$3.0M
Operating Profit$0$0$-1.0M$0$1.0M
Net Profit$0$0$-1.0M$0$0
EPS$-0.20$-0.10$-0.14$-0.02$0.01
Op Margin-58.4%-635.7%—-128.0%31.1%

Balance Sheet (USD)

Metric20172018201920202022
Total Assets$0$0$1.0M$3.0M$14.0M
Total Liabilities$0$0$0$2.0M$9.0M
Cash$0$0$0$0$0
Borrowings$0$0$0$2.0M$8.0M

Latest News

RTX (NYSE:RTX) Delivers First SPY 6(V)4 Radar Array For Navy Destroyer Upgrade Simply Wall St. · Aug 5, 2026 GE Aerospace Talks Less About The Shortage It Still Has Trefis · Aug 5, 2026 Kratos Defense Q2 Earnings and Revenues Outpace Estimates Zacks · Aug 5, 2026 Strength in Commercial Engines Unit Drives GE Aerospace: Can It Sustain? Zacks · Aug 5, 2026 Should Howmet Aerospace Shares be in Your Portfolio Pre-Q2 Earnings? Zacks · Aug 5, 2026

Cash Flow (USD)

Metric20172018201920202022
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$-9.0M
Financing Cash Flow$0$0$0$0$6.0M
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA9.46
FCF Yield-274.02%
Quick Ratio0.85
Interest Coverage1.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BOMObowmo, Inc. $0.00 — -0.05 $286894 0.00%
INTVIntegrated Ventures, Inc. $0.30 -12.02% -1.39 $1.84M 0.00%
LIQQFLiquid Meta Capital Holdings Ltd. $0.02 -68.55% 1.72 $875488 0.00%
LUPGFLoopUp Group plc $0.00 — -0.05 $824336 0.00%
MWRKMetaWorks Platforms, Inc. $0.01 — -0.57 $1.22M 0.00%

About Rayont Inc.

Rayont Inc., primarily operating through its subsidiary THF Holdings Pty Ltd., specializes in the development of medical devices and cancer treatments. Established in 2011, the company maintains its headquarters in Southport, Australia, and was formerly recognized as Velt International Group Inc.

Rayont Inc. is headquartered in AU.

Rayont Inc. (RAYT) stock trades at $0.03 with a market capitalization of $1.46M. The stock is valued at a price-to-earnings (P/E) ratio of 2.91, price-to-book of 0.27, price-to-sales of 0.51. Over the past 52 weeks the stock has ranged between $0.03 and $0.10, and currently trades 70.0% below its 52-week high.

On profitability, Rayont Inc. generates a return on equity (ROE) of 8.14%, return on capital employed of 8.57%, an operating margin of 31.15%, a net profit margin of 8.62%.

Official website: rayont.com

Related Technology Stocks

NVDA NVIDIA Corporation $214.13 -1.43% AAPL Apple Inc. $343.46 +0.43% MSFT Microsoft Corporation $529.05 -1.93% TSM Taiwan Semiconductor Manufacturing Company Ltd. $412.61 -2.28% AVGO Broadcom Inc. $328.75 -4.52% MU Micron Technology, Inc. $878.84 -5.63% AMD Advanced Micro Devices, Inc. $528.75 -5.95% ASML ASML Holding N.V. - New York Registry Shares $1641.52 -0.96% INTC Intel Corporation $89.85 -5.79% PLTR Palantir Technologies Inc. $186.03 -7.22% CSCO Cisco Systems, Inc. $107.39 -2.24% ORCL Oracle Corporation $128.22 -4.65%

Popular Stocks

Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Eli Lilly (LLY)JPMorgan (JPM)Visa (V)Exxon Mobil (XOM)Walmart (WMT)UnitedHealth (UNH)

Related stock screens

High ROE Technology StocksLow P/E Technology StocksHigh Net Margin Technology StocksDividend Technology StocksLow Debt Technology StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.